Comparing efficacy and safety between Naldebain(®) and intravenous patient-controlled analgesia with fentanyl for pain management post-laparotomy: study protocol for a randomized controlled, non-inferior trial

BACKGROUND: A long-acting prodrug of nalbuphine, nalbuphine sebacate, has been developed for meeting the unmet medical need of long-acting analgesics. Naldebain(®) (nalbuphine sebacate) has been developed as a new premedication for postoperative pain management. The primary objective of this study i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiang-Lin, Chang, Tsung-Kun, Su, Wei-Chih, Yeh, Yung-Sung, Huang, Ching-Wen, Ma, Cheng-Jen, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423831/
https://www.ncbi.nlm.nih.gov/pubmed/30885242
http://dx.doi.org/10.1186/s13063-019-3260-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423831/
https://www.ncbi.nlm.nih.gov/pubmed/30885242
http://dx.doi.org/10.1186/s13063-019-3260-4

Ejemplares similares